Khosla, Y Combinator Dominate July’s Venture Capital Activity

Venture capital investors showed no sign of slowing down in July, with artificial intelligence once again at the center of the busiest portfolios. Khosla Ventures emerged as the most active lead investor in rounds of $5 million or more, closing eight deals. The largest included a $300 million Series A for quantum computing startup Oratomic and a $120 million Series C for AI-powered legal tech company Norm AI.

When the lens widens to include both lead and follow-on investments, Y Combinator was far and away the most prolific participant, taking part in at least 19 qualifying rounds. The accelerator typically holds non-lead positions in follow-on financings of its alumni. Insight Partners and Andreessen Horowitz each recorded 10 deals, followed by Khosla and Index Ventures with nine apiece.

The heaviest spender of the month was Coatue, thanks to its participation in a $10 billion financing for Jeff Bezos’ rocket company Blue Origin. Although Blue Origin was founded in 2000 and stretches the conventional definition of a startup, it remains a privately held company. That deal skewed the dollar-weighted ranking and underscored how late-stage private companies now attract startup-style venture rounds.

What the July Rankings Signal About AI’s Grip on Early-Stage Funding

The AI Funding Engine Continues to Hum

July’s leaderboard was overwhelmingly shaped by deals in artificial intelligence and adjacent deep-tech fields such as quantum computing. Khosla’s top two rounds—Oratomic and Norm AI—both sit squarely in that camp, as did many of the rounds backed by Andreessen Horowitz and Insight Partners. This concentration mirrors a multi-quarter trend in which AI startups command a disproportionate share of venture dollars, driven by the belief that large language models and next-generation hardware will reshape entire industries. For generalist funds, skipping AI now means missing the bulk of high-growth opportunities.

Advertisement

Y Combinator’s Formula Keeps It at the Top

Y Combinator’s persistent No. 1 ranking by deal count reflects the accelerator model’s sheer volume advantage. Because it takes small, non-lead stakes in follow-on rounds of its hundreds of alumni, YC naturally appears in more $5 million-and-up rounds than any traditional venture firm. The strategy has proven resilient: even as early-stage competition intensifies, the accelerator’s brand continues to attract high-performing startups, which then feed its follow-on pipeline. The result is a deal count that no single-stage investor can match.

Blue Origin and the Blurring of Private Market Boundaries

Coatue’s $10 billion commitment to Blue Origin highlights a structural shift in private capital. Blue Origin is older than many public companies, yet it funded itself like a late-stage growth startup. This development fits a broader pattern in which founders and early backers stay private longer, sometimes raising billions in venture-style rounds well past what used to be the typical IPO window. For the VCs involved, it offers an alternative to public markets but also concentrates risk in assets with limited liquidity. The deal raises questions about whether such rounds should still be tracked alongside traditional startup investing metrics.

For Founders and Investors: Reading the July Deal Flow Tea Leaves

While July’s rankings are a snapshot rather than a predictive tool, they carry useful signals for those raising or deploying capital:

  • AI founders: competition for deals is fierce, but the capital is there. Khosla, Andreessen Horowitz and Insight Partners are specifically hunting for AI and deep-tech Series A to C rounds. A credible technical team with a prototype can likely get meetings even in a crowded funding environment.
  • Accelerator graduates should plan for Y Combinator follow-ons. YC’s presence in nearly 20 rounds last month shows the accelerator will reliably show up in alumni rounds. Founders should treat that as a ready source of bridge capital but not rely on it to anchor a round.
  • Late-stage private companies can distort industry data. Coatue’s Blue Origin bet skews the spending metric. Investors tracking the venture market should separate these mega-rounds from the core early-stage data to gauge the true health of startup formation.
  • Seed-stage founders face a crowded top tier. The top seed investors list remains dominated by a handful of names. Founders should consider building relationships with multiple potential leads early, as demand for the most active seed funds continues to outstrip supply.